OSE Immunotherapeutics appoints Marc Le Bozec as interim CEO
PositiveFinancial Markets

OSE Immunotherapeutics has appointed Marc Le Bozec as its interim CEO, a move that signals a strategic shift for the company. This change in leadership comes at a crucial time as the firm seeks to enhance its focus on immunotherapy solutions. Le Bozec's extensive experience in the biotech sector is expected to guide the company through its next phase of growth, making this appointment significant for stakeholders and investors alike.
— Curated by the World Pulse Now AI Editorial System